KPW
CTSO icon

Kore Private Wealth’s Cytosorbents Corp CTSO Stock Holding History

Kore Private Wealth’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,000
Closed -$8K – 356
2019
Q1 		$8K Hold
1,000
– – ﹤0.01% 659
2018
Q4 		$8K Buy
+1,000
New +$9.93K ﹤0.01% 591

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Kore Private Wealth's CTSO Position: Q2 2019 in Review

Kore Private Wealth sold out of Cytosorbents Corp (CTSO) in Q2 2019, closing a stake of 1,000 shares — an estimated $8K sold.

Kore Private Wealth first reported a position in CTSO in Q4 2018 and held it in 2 quarters. The position peaked at $8K in Q1 2019. 72 funds tracked by Wall St. Rank hold CTSO as of Q2 2019.

  • Kore Private Wealth reported no remaining Cytosorbents Corp position as of Q2 2019 after selling out during the quarter.
  • Kore Private Wealth sold 1,000 Cytosorbents Corp shares in Q2 2019, an estimated $8K.
  • Kore Private Wealth first reported a position in Cytosorbents Corp in Q4 2018 and held it in 2 quarters.
  • Kore Private Wealth's Cytosorbents Corp position peaked at $8K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2019.

Based on Kore Private Wealth's 13F filing for Q2 2019, filed 14 Aug 2019.